Skip to main content
TipRanks
Go Ultimate75% OFF

SAB Biotherapeutics (SABS) Q2 2023 Earnings Report

332 Followers

SABS Q2 2023 EPS Results

Actual EPS
-$1.40
Consensus EPS
-$1.40
Beat/Miss
Met expectations
One Year Ago EPS
-$1.10

SABS Q2 2023 Revenue Results

Actual Revenue
$85.52K
Expected Revenue
$400.00K
Beat/Miss
Missed by -$314.48K
YoY Revenue Growth
-98.65%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/21/2023
Time
Before Open
Conference Call
Monday, August 21, 2023
SABS Upcoming Earnings

SAB Biotherapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

SABS Earnings History

SABS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-0.24--0.35――
Nov 05, 20262026 (Q3)-0.28-0.24-0.21-14.29% (-0.03)
Aug 06, 20262026 (Q2)-0.29-0.28-1.0974.31% (+0.81)
May 12, 20262026 (Q1)-0.21-0.35-0.5637.50% (+0.21)
Mar 26, 20262025 (Q4)-0.21-0.27-1.2378.05% (+0.96)
Nov 13, 20252025 (Q3)-0.46-0.21-1.1281.25% (+0.91)
Aug 07, 20252025 (Q2)-0.80-1.09-0.79-37.97% (-0.30)
May 09, 20252025 (Q1)―--0.54―
Mar 31, 20252024 (Q4)-1.07-0.56-0.54-3.70% (-0.02)
Nov 06, 20242024 (Q3)-1.11-1.12-1-12.00% (-0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed